Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Amygdala Acquires GS-6637 from Gilead

Amygdala Neurosciences has agreed to acquire Gilead’s GS-6637, a highly selective ALDH2 inhibitor with the potential to treat behavior and substance addictions.

Read More »

Egalet painkiller wins FDA approval; label disappoints

The U.S. Food and Drug Administration approved Egalet Corp.’s Arymo ER and will allow the company to claim the long-acting opioid painkiller deters abuse by those seeking to dissolve and inject it.

Read More »

Partnership for Drug-Free Kids Announces National Launch of “Search and Rescue” Opioid Prescriber Education Campaign

Partnership for Drug-Free Kids announced the national launch of “Search and Rescue,” a prescriber education campaign that gives healthcare providers the resources they need to prescribe opioids responsibly and prevent the misuse and abuse of medicine in their practices.

Read More »

FDA panel backs approval of Pfizer’s opioid painkiller

A U.S. advisory panel recommended approval of Pfizer Inc’s long-acting opioid painkiller Troxyca ER, saying it dulls pain and its design could deter abuse by addicts in search of a quick high.

Read More »

FDA Approves First Implantable Device for Opioid Dependency

Titan Pharmaceuticals announced that the U.S. FDA approved Probuphine (buprenorphine) implant for long-term maintenance of opioid dependence.

Read More »

Obama calls for more funds, new attitude to fight opioid epidemic

With a nod to his own drug use as a young man, President Barack Obama on Tuesday called for more funding and a new approach to help people addicted to heroin and prescription drugs, seeking to shine a public spotlight on an increasingly deadly killer. During an appearance at a drug abuse summit in Atlanta, […]

Read More »

New York City finds one in five adults has mental health problems

At least one in five adult New Yorkers suffer from depression, substance abuse, suicidal thoughts or other psychological disorders every year, according to a report released on Thursday ahead of Mayor Bill de Blaiso’s new mental-health initiative.   New York City’s Department of Health and Mental Hygiene expects to release the plan, known as NYC […]

Read More »

Clinton proposes $7.5 billion U.S. fund to fight addiction

Democratic presidential candidate Hillary Clinton would launch a $10 billion initiative to tackle drug and alcohol addiction, a problem she speaks of often on the campaign trail and which affects 23 million Americans.   Clinton’s plan would include a new $7.5 billion federal fund to support states that launch addiction-related prevention, treatment, medical response, prescription […]

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

June 2019 Focus: Payer access, biotech/biopharma, DTC, rare diseases, and more!


Ad Right Bottom